just now   (707+ words) Prostate cancer remains one of the most commonly diagnosed malignancies in the world, and a new large-scale analysis from Brazil is shedding fresh light on which patients are most at risk of dying from the disease....

8+ min ago   (55+ words) Hepatocellular carcinoma, the most common form of primary liver cancer, remains one of the world’s most lethal malignancies, and its treatment options have changed surprisingly little over the past two decades. Now, a review published in Medical Oncology argues that…...

12+ min ago   (769+ words) Older adults undergoing cancer treatment face a hidden metabolic threat that has long slipped through the cracks of oncology care. Corticosteroids, which are woven into many chemotherapy regimens and supportive care protocols to suppress nausea, allergic reactions and immune-related toxicity,…...

12+ min ago   (650+ words) A closely watched Phase 3 clinical trial has delivered a sobering verdict on one of the most anticipated treatment strategies in lung cancer medicine....

24+ min ago   (661+ words) A single protein called BAX sits at the gateway between life and death for human cells. When tissues are injured, stressed, or deprived of oxygen, BAX springs into action, punching holes in the outer membrane of mitochondria and triggering the…...

24+ min ago   (69+ words) Small-cell lung cancer has long been one of oncology’s most punishing adversaries. It grows with astonishing speed, spreads early, and presents a treatment paradox that has frustrated clinicians for decades: at diagnosis, tumors melt away under platinum-based chemotherapy, yet relapse…...

27+ min ago   (672+ words) For decades, surgeons have operated on the assumption that when it comes to removing lymph nodes in cancer surgery, more is better. A thorough lymph node dissection has long been considered the gold standard, ensuring accurate staging and reducing the…...

35+ min ago   (485+ words) A sprawling review of the meadow rue genus, Thalictrum, has catalogued a striking trove of biologically active plant chemicals across Africa and Asia, while simultaneously exposing how little of the evidence stands up to rigorous scientific scrutiny....

35+ min ago   (55+ words) Pembrolizumab, one of the most widely prescribed cancer immunotherapies in the world, has long been dosed on the assumption that saturating the PD-1 receptor on T cells is the key to unlocking the immune system against tumours. A new translational…...

42+ min ago   (120+ words) Adoptive T cell therapy has delivered striking remissions in some blood cancers, but its promise in solid tumors has been repeatedly undermined by a stubborn problem: the therapeutic cells do not last. Engineered T cells that flood a tumor and…...